{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:39:24Z","timestamp":1787499564124,"version":"build-2736575974"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2013,1,16]],"date-time":"2013-01-16T00:00:00Z","timestamp":1358294400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0054525","type":"journal-article","created":{"date-parts":[[2013,1,16]],"date-time":"2013-01-16T16:51:50Z","timestamp":1358355110000},"page":"e54525","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":45,"title":["Inhibition of Ceramide Metabolism Sensitizes Human Leukemia Cells to Inhibition of BCL2-Like Proteins"],"prefix":"10.1371","volume":"8","author":[{"given":"Lavona","family":"Casson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley A.","family":"Mathews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel","family":"Southall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajarshi","family":"Guha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah J.","family":"Siskind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levi J.","family":"Beverly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,1,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"D Hanahan","year":"2000","journal-title":"Cell"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1126\/science.281.5381.1322","article-title":"The Bcl-2 protein family: arbiters of cell survival","volume":"281","author":"JM Adams","year":"1998","journal-title":"Science"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1046\/j.1365-2443.1998.00223.x","article-title":"Role of Bcl-2 family proteins in apoptosis: apoptosomes or mitochondria?","volume":"3","author":"Y Tsujimoto","year":"1998","journal-title":"Genes Cells"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1042\/BJ20112103","article-title":"Bax and Bcl-xL exert their regulation on different sites of the ceramide channel","volume":"445","author":"MN Perera","year":"2012","journal-title":"Biochem J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: lessons from sphingolipids","volume":"9","author":"YA Hannun","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"8590","DOI":"10.1038\/sj.onc.1207102","article-title":"The Bcl-2 family: roles in cell survival and oncogenesis","volume":"22","author":"S Cory","year":"2003","journal-title":"Oncogene"},{"key":"ref7","first-page":"1701s","article-title":"Genetic control of programmed cell death in the nematode Caenorhabditis elegans","volume":"59","author":"HR Horvitz","year":"1999","journal-title":"Cancer Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ccr.2004.07.011","article-title":"Antiapoptotic BCL-2 is required for maintenance of a model leukemia","volume":"6","author":"A Letai","year":"2004","journal-title":"Cancer Cell"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nature03579","article-title":"An inhibitor of Bcl-2 family proteins induces regression of solid tumours","volume":"435","author":"T Oltersdorf","year":"2005","journal-title":"Nature"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/sj.cdd.4401975","article-title":"Proapoptotic multidomain Bcl-2\/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities","volume":"13","author":"JC Reed","year":"2006","journal-title":"Cell Death Differ"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1158\/0008-5472.CAN-07-5836","article-title":"ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor","volume":"68","author":"C Tse","year":"2008","journal-title":"Cancer research"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ccr.2006.08.027","article-title":"The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak\/Bax if Mcl-1 is neutralized","volume":"10","author":"MF van Delft","year":"2006","journal-title":"Cancer Cell"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"19512","DOI":"10.1073\/pnas.0709443104","article-title":"Small molecule obatoclax (GX15\u2013070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis","volume":"104","author":"M Nguyen","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1182\/blood-2007-06-098012","article-title":"BCL-2 dependence and ABT-737 sensitivity in acute lymphoblastic leukemia","volume":"111","author":"V Del Gaizo Moore","year":"2008","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ccr.2006.10.006","article-title":"Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia","volume":"10","author":"M Konopleva","year":"2006","journal-title":"Cancer Cell"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S1470-2045(10)70261-8","article-title":"Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity","volume":"11","author":"WH Wilson","year":"2010","journal-title":"The lancet oncology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"11818","DOI":"10.1074\/jbc.M109.078121","article-title":"The BCL-2 protein BAK is required for long-chain ceramide generation during apoptosis","volume":"285","author":"LJ Siskind","year":"2010","journal-title":"J Biol Chem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.mito.2006.03.002","article-title":"Ceramide forms channels in mitochondrial outer membranes at physiologically relevant concentrations","volume":"6","author":"LJ Siskind","year":"2006","journal-title":"Mitochondrion"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1038\/sj.onc.1201023","article-title":"Influence of Bcl-2 overexpression on the ceramide pathway in daunorubicin-induced apoptosis of leukemic cells","volume":"14","author":"M Allouche","year":"1997","journal-title":"Oncogene"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1042\/bj3360735","article-title":"Distinct sites of action of Bcl-2 and Bcl-xL in the ceramide pathway of apoptosis","volume":"3)","author":"W El-Assaad","year":"1998","journal-title":"Biochem J 336 (Pt"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.febslet.2010.02.032","article-title":"Regulation of ceramide channels by Bcl-2 family proteins","volume":"584","author":"V Ganesan","year":"2010","journal-title":"FEBS Lett"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0014-5793(96)01284-7","article-title":"Ceramides induce a form of apoptosis in human acute lymphoblastic leukemia cells that is inhibited by Bcl-2, but not by CrmA","volume":"400","author":"S Geley","year":"1997","journal-title":"FEBS Lett"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0014-4827(03)00098-3","article-title":"Transmembrane domain of Bcl-2 is required for inhibition of ceramide synthesis, but not cytochrome c release in the pathway of inostamycin-induced apoptosis","volume":"286","author":"M Kawatani","year":"2003","journal-title":"Exp Cell Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1038\/sj.onc.1203699","article-title":"Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells","volume":"19","author":"M Sawada","year":"2000","journal-title":"Oncogene"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1073\/pnas.93.11.5325","article-title":"Bcl-2 interrupts the ceramide-mediated pathway of cell death","volume":"93","author":"J Zhang","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00432-011-1016-y","article-title":"Targeting glucosylceramide synthase sensitizes imatinib-resistant chronic myeloid leukemia cells via endogenous ceramide accumulation","volume":"137","author":"Y Baran","year":"2011","journal-title":"Journal of cancer research and clinical oncology"},{"key":"ref27","first-page":"415","article-title":"Possible role of ceramide as an indicator of chemoresistance: decrease of the ceramide content via activation of glucosylceramide synthase and sphingomyelin synthase in chemoresistant leukemia","volume":"9","author":"M Itoh","year":"2003","journal-title":"Clin Cancer Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1194\/jlr.M300486-JLR200","article-title":"Oligonucleotides blocking glucosylceramide synthase expression selectively reverse drug resistance in cancer cells","volume":"45","author":"YY Liu","year":"2004","journal-title":"J Lipid Res"},{"key":"ref29","first-page":"156","article-title":"Messner MC, Cabot MC Glucosylceramide in humans","volume":"688","journal-title":"Adv Exp Med Biol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1016\/j.febslet.2006.09.070","article-title":"Sphingosine kinase-1 is cleaved by cathepsin B in vitro: identification of the initial cleavage sites for the protease","volume":"580","author":"TA Taha","year":"2006","journal-title":"FEBS Lett"},{"key":"ref31","first-page":"113","article-title":"Sphingosine kinase: biochemical and cellular regulation and role in disease","volume":"39","author":"TA Taha","year":"2006","journal-title":"J Biochem Mol Biol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ymeth.2006.05.004","article-title":"Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry","volume":"39","author":"J Bielawski","year":"2006","journal-title":"Methods"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1074\/jbc.270.6.2859","article-title":"Cell cycle arrest induced by an inhibitor of glucosylceramide synthase. Correlation with cyclin-dependent kinases","volume":"270","author":"CS Rani","year":"1995","journal-title":"The Journal of biological chemistry"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2337\/db06-1619","article-title":"Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity","volume":"56","author":"JM Aerts","year":"2007","journal-title":"Diabetes"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.bbabio.2010.01.021","article-title":"Ceramide channels and their role in mitochondria-mediated apoptosis","volume":"1797","author":"M Colombini","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Siskind LJ, Feinstein L, Yu T, Davis JS, Jones D, <etal>et al<\/etal>.. (2008) Anti-apoptotic Bcl-2 family proteins disassemble ceramide channels. J Biol Chem.","DOI":"10.1074\/jbc.M706115200"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0014-5793(01)02836-8","article-title":"Bax-dependent apoptosis induced by ceramide in HL-60 cells","volume":"505","author":"HJ Kim","year":"2001","journal-title":"FEBS Lett"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1038\/sj.onc.1205497","article-title":"Ceramide induces mitochondrial activation and apoptosis via a Bax-dependent pathway in human carcinoma cells","volume":"21","author":"C von Haefen","year":"2002","journal-title":"Oncogene"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.cell.2012.01.038","article-title":"Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis","volume":"148","author":"JE Chipuk","year":"2012","journal-title":"Cell"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10495-009-0449-0","article-title":"Ceramide and activated Bax act synergistically to permeabilize the mitochondrial outer membrane","volume":"15","author":"V Ganesan","year":"2010","journal-title":"Apoptosis"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.3109\/10428194.2011.568653","article-title":"Roles of ceramide synthase and ceramide clearence genes in nilotinib-induced cell death in chronic myeloid leukemia cells","volume":"52","author":"A Camgoz","year":"2011","journal-title":"Leukemia & lymphoma"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1080\/01635581.2011.538485","article-title":"Resveratrol triggers apoptosis through regulating ceramide metabolizing genes in human K562 chronic myeloid leukemia cells","volume":"63","author":"M Kartal","year":"2011","journal-title":"Nutrition and cancer"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1038\/sj.onc.1207357","article-title":"Overcoming resistance to gamma-rays in squamous carcinoma cells by poly-drug elevation of ceramide levels","volume":"23","author":"G Alphonse","year":"2004","journal-title":"Oncogene"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/hed.21418","article-title":"Increased radiation sensitivity of head and neck squamous cell carcinoma with sphingosine kinase 1 inhibition","volume":"33","author":"UK Sinha","year":"2011","journal-title":"Head & neck"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"18256","DOI":"10.1074\/jbc.M314105200","article-title":"Cytoprotective effect of glucosylceramide synthase inhibition against daunorubicin-induced apoptosis in human leukemic cell lines","volume":"279","author":"S Grazide","year":"2004","journal-title":"The Journal of biological chemistry"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12185-008-0052-0","article-title":"Implications of sphingosine kinase 1 expression level for the cellular sphingolipid rheostat: relevance as a marker for daunorubicin sensitivity of leukemia cells","volume":"87","author":"S Sobue","year":"2008","journal-title":"International journal of hematology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1111\/j.1476-5381.2012.01862.x","article-title":"Resveratrol dimers are novel sphingosine kinase 1 inhibitors and affect sphingosine kinase 1 expression and cancer cell growth and survival","volume":"166","author":"KG Lim","year":"2012","journal-title":"British journal of pharmacology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1096\/fj.09-130542","article-title":"Resveratrol attenuates C5a-induced inflammatory responses in vitro and in vivo by inhibiting phospholipase D and sphingosine kinase activities","volume":"23","author":"PD Issuree","year":"2009","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.3324\/haematol.2009.008078","article-title":"Real-world clinical experience with long-term miglustat maintenance therapy in type 1 Gaucher disease: the ZAGAL project","volume":"94","author":"P Giraldo","year":"2009","journal-title":"Haematologica"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1042\/BJ20111929","article-title":"Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1","volume":"444","author":"ME Schnute","year":"2012","journal-title":"The Biochemical journal"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0054525","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T07:14:41Z","timestamp":1562570081000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0054525"}},"subtitle":[],"editor":[{"given":"Daniel T.","family":"Starczynowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,1,16]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,1,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0054525","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,16]]}}}